Case | Sex | Age at onset (y) | Age at death (y) | Duration (y) | Initial symptoms | Spastic paraparesis | Parkinsonism | Brain weight (g) | CWPs | Lewy body disease | PSEN1 mutation | References |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | f | 25 | 54 | 29 | cognitive impairment | + | + | 895 | + | diffuse | G417S | Present case |
2 | n.d. | 29 | n.d. | n.d. | spastic paraparesis | + | n.d. | n.d. | + | n.d. | P436Q | Houlden H et al. [6] |
3 | m | 30s | 48 | n.a. | disorientation | – | n.d. | n.d. | + | n.d. | L420R | Shrimpton AE et al. (II:1) [20] |
4 | f | 31 | 43 | 12 | forgetfulness | – | + | 1170 | + | – | L420R | Niwa A et al. [14] |
5 | m | 34 | 39 | 5 | morbid jealousy | – | n.d. | 1550 | + | n.d | deletion of exon 9 sequence from PSEN1 transcripts | Brooks WS et al. (EOFAD-2 IV:45) [3] |
6 | m | 34 | 52 | 18 | parkinsonism | – | + | 1150 | + | diffuse | in-frame 3bp ACC deletion in exon 12 | Ishikawa A et al. [8] |
7 | n.d. | 36 | n.d. | n.d. | spastic paraparesis | + | n.d. | n.d. | + | n.d. | Δ83,84IM | Houlden H et al. [6] |
8 | f | 37 | 50 | 13 | cognitive dysfunction, parkinsonism | + | + | 740 | + | limbic | G217D | Takao M et al. (case III-2) [23] |
9 | f | 40 | biopsy | n.a. | cognitive impairment | + | n.d. | biopsy | + | n.d. | E280G | O’Riordan S et al. (patient 3) [17] |
10 | f | 41 | 45 | 4 | cognitive decline | – | n.d. | 992 | + | n.d. | G- > T exon 9 splice acceptor mutation | Brooks WS et al. (EOFAD-3 II:10) [3] |
11 | m | 41 | 46 | 5 | dementia | n.d. | n.d. | n.d. | + | n.d. | deletion of exon 9 | Smith MJ et al. (case II:12) [22] |
12 | m | 42 | 46 | 4 | antiflexion gait | + | + | 1150 | + | – | G217D | Takao M et al. (case III-1) [23] |
13 | f | 46 | 52 | 6 | memory loss and disorientation | – | n.d. | 1144 | + | n.d. | G217R | Norton JB et al. (case 4:4) [15] |
14 | m | 46 | 65 | 19 | depression | + | + | 1100 | + | – | P264L | Martikinen P et al. (case 3) [12] |
15 | f | 47 | 51 | 4 | cognitive decline | + | n.d. | n.d. | + | n.d. | G- > T exon 9 splice acceptor mutation | Brooks WS et al. (EOFAD-3 II:8) [3] |
16 | m | 47 | 67 | 20 | spasticity and weakness in legs | + | n.d. | 1110 | + | – | E280G | Sinha N et al. [21] |
17 | f | 50 | 53 | 3 | spastic paraparesis | + | n.d. | n.d. | + | n.d. | deletion of exon 9 | Smith MJ et al. (case III:9) [22] |
18 | f | 50 | 60 | 10 | cognitive decline | – | n.d. | 918 | + | n.d. | deletion of exon 9 sequence from PSEN1 transcripts | Brooks WS et al. (EOFAD-2 III:18) [3] |
19 | f | 51 | 68 | 17 | memory impairment | – | + | 1050 | + | – | P264L | Martikinen P et al. (case 1) [12] |
20 | m | 52 | 56 | 4 | cognitive decline | – | n.d. | 910 | + | n.d. | deletion of exon 9 sequence from PSEN1 transcripts | Brooks WS et al. (EOFAD-2 IV:23) [3] |
21 | m | 52 | 56 | 4 | dementia | n.d. | n.d. | n.d. | + | n.d. | deletion of exon 9 | Smith MJ et al. (case II:7) [22] |
22 | m | 52 | 67 | 15 | memory difficulty and weakness in both legs | + | n.d. | 890 | + | n.d. | E280Q | Rogaeva E et al. [18] |
23 | f | 54 | 63 | 9 | dementia and spastic paraparesis | + | n.d. | n.d. | + | n.d. | deletion of exon 9 | Smith MJ et al. case (III:7) [22] |
24 | m | 54 | 64 | 10 | dementia | + | n.d. | 1360 | + | n.d. | deletion of exon 9 | Crook R et al. (case III:15) [4] |
25 | m | 55 | 61 | 6 | back pain, stiffness of legs | + | n.d. | n.d. | + | n.d. | deletion of exon 9 splice site | Crook R et al. (patient III:9) [4] |
26 | m | 57 | 69 | 12 | dementia | + | n.d. | 1075 | + | n.d. | deletion of exon 9 | Crook R et al. (case III:14) [4] |
27 | m | 58 | 75 | 17 | memory impairment | + | – | 1320 | + | – | P264L | Martikinen P et al. (case 2) [12] |
28 | f | n.d. | 60 | n.a. | n.d. | – | n.d. | n.d. | + | n.d. | L271V | Kwok JB et al. (III:28) [10] |